BioHarvest Sciences Inc. Common Stock (BHST) 은(는) 상장 기업입니다 기초소재 섹터의 Agricultural Inputs 산업에서 운영. 본사 소재지는 Vancouver, BC, 캐나다. 현재 CEO는 Ilan Sobel.
BHST 을(를) 보유 IPO 날짜 2021-01-08, 87 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $73.99M.
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
